Cargando…

P09-12. Autologous neutralizing antibodies in early subtype C HIV-1 infection target variable regions of envelope and drive multiple pathways of viral escape

Detalles Bibliográficos
Autores principales:	Rong, R, Li, B, Haaland, RE, Murphy, MK, Mulenga, J, Allen, SA, Blackwell, JL, Pinter, A, Shaw, GM, Gnanakaran, S, Hunter, E, Robinson, JE, Derdeyn, CA
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767610/ http://dx.doi.org/10.1186/1742-4690-6-S3-P125

Ejemplares similares

P09-01. Mutation of the gp120 alpha2 helix in early subtype C HIV-1 infection fails to alter neutralization sensitivity or efficiency of in vitro replication
por: Murphy, MK, et al.
Publicado: (2009)

Escape from Autologous Neutralizing Antibodies in Acute/Early Subtype C HIV-1 Infection Requires Multiple Pathways
por: Rong, Rong, et al.
Publicado: (2009)

Sequential exposure to specific antibody escape mutations may program neutralization breadth during subtype A HIV-1 infection
por: Murphy, MK, et al.
Publicado: (2012)

A Mechanistic Understanding of Allosteric Immune Escape Pathways in the HIV-1 Envelope Glycoprotein
por: Sethi, Anurag, et al.
Publicado: (2013)

P09-04. Charge changes in the alpha2-helix in the C3 region of the HIV-1 subtype C envelope mediate neutralization escape
por: Moore, PL, et al.
Publicado: (2009)

Viral Escape from Neutralizing Antibodies in Early Subtype A HIV-1 Infection Drives an Increase in Autologous Neutralization Breadth
por: Murphy, Megan K., et al.
Publicado: (2013)

Effect of Glycosylation on an Immunodominant Region in the V1V2 Variable Domain of the HIV-1 Envelope gp120 Protein
por: Tian, Jianhui, et al.
Publicado: (2016)

HIV-1 subtype C superinfected individuals mount low autologous neutralizing antibody responses prior to intrasubtype superinfection
por: Basu, Debby, et al.
Publicado: (2012)

Intrasubtype C superinfected individuals mount delayed and low-titer autologous neutralizing antibody responses prior to superinfection
por: Basu, D, et al.
Publicado: (2012)

P04-09. Induction of cross-clade neutralizing antibodies with a prime/boost vaccine strategy focused on a neutralizing epitope
por: Zolla-Pazner, S, et al.
Publicado: (2009)

P09-17. Evolution of HLA-B*5703 HIV-1 escape mutations and their impact on HIV-1 replicative capacity
por: Crawford, H, et al.
Publicado: (2009)

Heterologous neutralization breadth persists despite B-lymphocyte dysfunction in chronic HIV-1 infection
por: Murphy, MK, et al.
Publicado: (2012)

P03-07. Autologous neutralizing antibodies that select viral escape variants emerge late after SIV infection of rhesus monkeys
por: Yeh, WW, et al.
Publicado: (2009)

P09-02. Selection pressure of neutralizing antibodies and viral escape continues in late stages of the disease
por: Rusert, P, et al.
Publicado: (2009)

The effect of single mutations in Zika virus envelope on escape from broadly neutralizing antibodies
por: Kikawa, Caroline, et al.
Publicado: (2023)

The effect of single mutations in Zika virus envelope on escape from broadly neutralizing antibodies
por: Kikawa, Caroline, et al.
Publicado: (2023)

High throughput analysis of B cell dynamics and neutralizing antibody development during immunization with a novel clade C HIV-1 envelope
por: Mopuri, Rohini, et al.
Publicado: (2023)

Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth
por: Smith, S. Abigail, et al.
Publicado: (2016)

Oncolytic herpes simplex virus tumor targeting and neutralization escape by engineering viral envelope glycoproteins
por: Liu, Xiao-Qin, et al.
Publicado: (2018)

Genetic Signatures in the Envelope Glycoproteins of HIV-1 that Associate with Broadly Neutralizing Antibodies
por: Gnanakaran, S., et al.
Publicado: (2010)

P09-07. Balancing reversion of CTL and neutralizing antibody escape mutations within HIV-1 Env upon transmission
por: Peut, V, et al.
Publicado: (2009)

The Glycan Hole Area of HIV-1 Envelope Trimers Contributes Prominently to the Induction of Autologous Neutralization
por: Schorcht, Anna, et al.
Publicado: (2022)

HIV-1 escapes from N332-directed antibody neutralization in an elite neutralizer by envelope glycoprotein elongation and introduction of unusual disulfide bonds
por: van den Kerkhof, Tom L. G. M., et al.
Publicado: (2016)

The C3/465 glycan hole cluster in BG505 HIV-1 envelope is the major neutralizing target involved in preventing mucosal SHIV infection
por: Charles, Tysheena P., et al.
Publicado: (2021)

HIV-1 clade C escapes broadly neutralizing autologous antibodies with N332 glycan specificity by distinct mechanisms
por: Deshpande, Suprit, et al.
Publicado: (2016)

P09-06. HIV-1 escape from broadly neutralizing anti-CD4 binding site NAbs during HIV-1 infection
por: Sather, D, et al.
Publicado: (2009)

Preventing escape from neutralizing antibodies
por: Brown, Matthew
Publicado: (2020)

Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients
por: Goepfert, Paul A., et al.
Publicado: (2008)

A neutralizing antibody target in early HIV-1 infection was recapitulated in rhesus macaques immunized with the transmitted/founder envelope sequence
por: Welbourn, Sarah, et al.
Publicado: (2022)

HIV envelope trimer-elicited autologous neutralizing antibodies bind a region overlapping the N332 glycan supersite
por: Nogal, Bartek, et al.
Publicado: (2020)

P04-43. Neutralizing antibody responses against conformational envelope epitopes in early HIV-1 infection
por: Bar, KJ, et al.
Publicado: (2009)

Continuous HIV-1 Escape from Autologous Neutralization and Development of Cross-Reactive Antibody Responses Characterizes Slow Disease Progression of Children
por: Dispinseri, Stefania, et al.
Publicado: (2021)

Harnessing the protective potential of HIV-1 neutralizing antibodies
por: Smith, S Abigail, et al.
Publicado: (2016)

P09-10. Impact of CTL escape mutations in HIV-1 Nef on viral replication
por: Oniangue-Ndza, C, et al.
Publicado: (2009)

A Signature in HIV-1 Envelope Leader Peptide Associated with Transition from Acute to Chronic Infection Impacts Envelope Processing and Infectivity
por: Asmal, Mohammed, et al.
Publicado: (2011)

P06-09. Web based interviewing system for HIV-behavior research in the settings of vaccine and non vaccine prevention trials
por: Peinado, JE, et al.
Publicado: (2009)

Characterization of V1V2-specific antibodies present in broadly neutralizing plasma isolated from HIV-1 infected individuals
por: Krachmarov, C, et al.
Publicado: (2012)

Neutralizing and non-neutralizing antibody responses in HIV-1 subtype C chronically infected patients with divergent rates of disease progression
por: Archary, D, et al.
Publicado: (2012)

Complete mapping of viral escape from neutralizing antibodies
por: Doud, Michael B., et al.
Publicado: (2017)

Delta-Omicron recombinant escapes therapeutic antibody neutralization
por: Duerr, Ralf, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kt2p61j8me7chemhtekeuostmp